Funding
Norwegian biotech startup Vitroscope secures $7M to scale living human tissue technology
Key Facts
Signal Type
Funding
Industry
Biotech
Companies
Vitroscope, Cerberus Ventures, YZR Capital
Date
November 3, 2026
Vitroscope, a Trondheim-based biotech startup, raised $7 million in a financing package, comprising a $5 million seed round co-led by Cerberus Ventures and YZR Capital, alongside $2 million in additional funding. The company is developing technology for studying living human tissue.
Vitroscope's operations will expand as it scales its platform. The funding also signals investor confidence in Nordic biotech innovation, affecting competitive dynamics in the region.
Watch for Vitroscope's hiring and technology adoption in the coming quarters. Also monitor follow-on funding and potential enterprise partnerships that could open doors for vendors.
Source:
ArcticStartupGet biotech signals in your CRM
FDA approvals and rejections, clinical trial results, pharma M&A, drug recalls, and funding rounds.
